Table 3.
Five-year relative survival rates of lung cancer patient by sex and histological subtypes, the Korea Central Cancer Registry, 1993-2012
| Histological group | Year of diagnosis |
Changea) (%) | p-valueb) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1993-1997 |
1998-2002 |
2003-2007 |
2008-2012 |
1993-2012 |
||||||||
| No. | 5-Year survival (%) | No. | 5-Year survival (%) | No. | 5-Year survival (%) | No. | 5-Year survival (%) | No. | 5-Year survival (%) | |||
| Overall total | 37,145 | 12.0 | 59,279 | 14.3 | 73,116 | 17.4 | 88,559 | 21.9 | 258,099 | 17.4 | 9.9 | < 0.01 |
| Carcinoma | 29,798 | 11.5 | 45,528 | 14.2 | 59,851 | 18.4 | 76,061 | 23.9 | 211,238 | 18.3 | 12.4 | < 0.01 |
| Squamous cell carcinoma | 13,431 | 13.6 | 18,209 | 16.4 | 20,631 | 19.5 | 22,165 | 22.2 | 74,436 | 18.4 | 8.6 | < 0.01 |
| Adenocarcinoma | 8,841 | 10.4 | 15,490 | 14.6 | 22,148 | 23.1 | 34,187 | 32.1 | 80,666 | 23.4 | 21.7 | < 0.01 |
| Small-cell carcinoma | 5,179 | 6.2 | 7,467 | 8.0 | 8,739 | 7.5 | 10,432 | 8.0 | 31,817 | 7.6 | 1.8 | < 0.01 |
| Large-cell carcinoma | 1,834 | 9.7 | 3,229 | 9.3 | 1,824 | 10.6 | 1,555 | 12.6 | 8,442 | 10.2 | 2.9 | 0.42 |
| Other specified carcinomas | 513 | 33.2 | 1,133 | 30.4 | 6,509 | 15.2 | 7,722 | 17.0 | 15,877 | 17.8 | –16.2 | < 0.01 |
| Sarcoma | 71 | 18.0 | 118 | 20.5 | 153 | 12.5 | 150 | 23.1 | 492 | 17.6 | 5.1 | 0.88 |
| Other specified cancer | 55 | 28.0 | 54 | 32.1 | 59 | 47.2 | 66 | 22.7 | 234 | 33.3 | –5.3 | 0.35 |
| Unspecified cancer | 7,221 | 14.0 | 13,579 | 14.3 | 13,053 | 13.1 | 12,282 | 8.9 | 46,135 | 12.7 | –5.1 | < 0.01 |
| Men | ||||||||||||
| Total | 28,695 | 11.2 | 44,342 | 12.9 | 53,690 | 15.9 | 62,863 | 19.3 | 189,590 | 15.5 | 8.1 | < 0.01 |
| Carcinoma | 23,575 | 11.1 | 35,235 | 13.5 | 45,080 | 17.0 | 54,900 | 21.0 | 158,790 | 16.6 | 9.9 | < 0.01 |
| Squamous cell carcinoma | 12,099 | 13.7 | 16,493 | 16.5 | 18,705 | 20.0 | 20,099 | 22.7 | 67,396 | 18.7 | 9.0 | < 0.01 |
| Adenocarcinoma | 5,366 | 9.0 | 9,263 | 12.4 | 12,747 | 19.9 | 19,087 | 27.1 | 46,463 | 19.8 | 18.1 | < 0.01 |
| Small-cell carcinoma | 4,299 | 5.6 | 6,197 | 7.5 | 7,298 | 7.4 | 8,694 | 8.2 | 26,488 | 7.4 | 2.6 | < 0.01 |
| Large-cell carcinoma | 1,450 | 9.4 | 2,500 | 8.9 | 1,424 | 10.5 | 1,198 | 13.4 | 6,572 | 10.1 | 4.0 | 0.17 |
| Other specified carcinomas | 361 | 28.6 | 782 | 25.0 | 4,906 | 14.0 | 5,822 | 15.9 | 11,871 | 16.1 | –12.7 | < 0.01 |
| Sarcoma | 45 | 16.8 | 82 | 15.6 | 95 | 7.0 | 110 | 21.5 | 332 | 14.3 | 4.7 | 0.89 |
| Other specified cancer | 44 | 28.2 | 36 | 25.2 | 44 | 37.4 | 42 | 18.2 | 166 | 28.1 | –10.0 | 0.20 |
| Unspecified cancer | 5,031 | 11.2 | 8,989 | 10.3 | 8,471 | 10.0 | 7,811 | 7.2 | 30,302 | 9.7 | –4.0 | < 0.01 |
| Women | ||||||||||||
| Total | 8,450 | 14.7 | 14,937 | 18.3 | 19,426 | 21.7 | 25,696 | 28.2 | 68,509 | 22.4 | 13.5 | < 0.01 |
| Carcinoma | 6,223 | 12.7 | 10,293 | 16.8 | 14,771 | 22.6 | 21,161 | 31.5 | 52,448 | 23.4 | 18.8 | < 0.01 |
| Squamous cell carcinoma | 1,332 | 12.3 | 1,716 | 15.2 | 1,926 | 15.1 | 2,066 | 17.3 | 7,040 | 15.2 | 5.0 | 0.02 |
| Adenocarcinoma | 3,475 | 12.6 | 6,227 | 17.8 | 9,401 | 27.5 | 15,100 | 38.3 | 34,203 | 28.2 | 25.7 | < 0.01 |
| Small-cell carcinoma | 880 | 9.1 | 1,270 | 10.5 | 1,441 | 8.3 | 1,738 | 7.1 | 5,329 | 8.7 | –2.0 | < 0.01 |
| Large-cell carcinoma | 384 | 10.8 | 729 | 10.8 | 400 | 10.7 | 357 | 9.5 | 1,870 | 10.7 | –1.3 | 0.39 |
| Other specified carcinomas | 152 | 44.1 | 351 | 42.1 | 1,603 | 18.8 | 1,900 | 20.5 | 4,006 | 23.0 | –23.6 | < 0.01 |
| Sarcoma | 26 | 20.1 | 36 | 31.6 | 58 | 21.2 | 40 | 27.0 | 160 | 24.3 | 6.9 | 0.95 |
| Other specified cancer | 11 | 27.5 | 18 | 45.3 | 15 | 76.0 | 24 | 31.4 | 68 | 46.2 | 3.9 | 0.99 |
| Unspecified cancer | 2,190 | 20.5 | 4,590 | 22.0 | 4,582 | 18.9 | 4,471 | 11.8 | 15,833 | 18.5 | –8.7 | < 0.01 |
a)
Change (%) in the 5-year relative survival rates from 1993-1997 to 2008-2012,
b)
p-values for changes in survival from 1993-1997 and 2008-2012 were derived by relative excess risk model.